Castleark Management LLC Charles River Laboratories International, Inc. Transaction History

Castleark Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $831,804 - $1.06 Million	4,220 New	4,220 $919,000
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $6.96 Million - $8.98 Million	-39,670 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $1.46 Million - $2.32 Million	-12,250 Reduced 23.59%	39,670 $6.92 Million
Q1 2020 May 13, 2020	BUY	$98.9 - $178.34 $5.13 Million - $9.26 Million	51,920 New	51,920 $6.55 Million
Q4 2017 Feb 15, 2018	SELL	$100.43 - $118.09 $503,154 - $591,630	-5,010 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$96.72 - $109.26 $484,567 - $547,392	5,010	5,010 $541,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.